Faculty

Vishwajit L Nimgaonkar, MD, PhD

Professor of Psychiatry and Human Genetics

Contact Details

3811 O'Hara St.
Pittsburgh
 
PA
 
15213

Education & Training

MD
Madras University, Christian Medical College
PhD
Neuropharmacology, University of Oxford, Faculty of Medicine
Medicine, Surgery, Obstetrics, Gynecology, and Community Health, Christian Medical College
Psychiatry, Western Psychiatric Institute and Clinic of UPMC
Psychiatry, Maudsley Hospital, London, United Kingdom
Biochemistry, University of London, United Kingdom
Biochemistry, University of London, United Kingdom

Specialty Certifications

Board Certification
American Board of Psychiatry and Neurology

Current Appointments

Director, Program for Genetics and Psychosis

Professional Affiliations

Fellow, American College of Neuropsychopharmacology
Member, Society of Biological Psychiatry
Member, International Society of Psychiatric Genetics
Member, American Society of Human Genetics
Member, Royal College of Psychiatrists, UK

Selected Honors & Awards

International Mentorship Award, Department of Psychiatry, University of Pittsburgh School of Medicine
Sir Dennis Hill Prize for Best Psychiatric Resident, Maudsley Hospital, Institute of Psychiatry, United Kingdom
Rhodes Scholarship, Rhodes Trust, India

Research Interests

Interventions for severe mental illness; Cellular models for psychosis; Neurovirology
Selected Research Publications & Products
  1. D'Aiuto L, Caldwell JK, Edwards TG, Zhou C, McDonald ML, Di Maio R, Joel WA, Hyde VR, Wallace CT, Watkins SC, Wesesky MA, Shemesh OA, Nimgaonkar VL, Bloom DC. Phosphorylated-tau associates with HSV-1 chromatin and correlates with nuclear speckles decondensation in low-density host chromatin regions. Neurobiol Dis. 2025 Mar;206:106804. doi: 10.1016/j.nbd.2025.106804. Epub 2025 Jan 14. PMID: 39818277; PMCID: PMC12001802.
  2. Chen X, Liu Y, Cue J, Han MV, Nimgaonkar VL, Weinberger D, Han S, Zhao Z, Chen J. (2025) Classification of schizophrenia, bipolar disorder and major depressive disorder with comorbid traits and deep learning algorithms. Schizophrenia. Res Sq [Preprint]. 11(1):14. doi: 10.1038/s41537-025-00564-7. PMID: 39910091
  3. Ganapathiraju MK, Bhatia T, Deshpande S, Wesesky M, Wood J, Nimgaonkar VL. (2024). Schizophrenia interactome-derived repurposable drugs and eandomized controlled trials of rwo xandidates. Biol Psychiatry. 96(8):651-658. doi: 10.1016/j.biopsych.2024.06.022. Epub 2024 Jun 29. PMID: 38950808.
  4. Rupert PE, Roalf DR, Prasad KM, Kuo SS, Musket CW, Wood J, Gur RC, Almasy L, Gur RE, Nimgaonkar VL, Pogue-Geile MF. Genetic risk for schizophrenia and brain activation during the Penn Conditional Exclusion Test: A multiplex extended pedigree study. J Psychopathol Clin Sci. 2025 Apr;134(3):272-283. doi: 10.1037/abn0000973. Epub 2025 Feb 27. PMID: 40014520; PMCID: PMC11949699.
  5. Bhatia T, Kumari N, Yadav A, Beniwal RP, Shah G, Joel W, Jones JR, Iyenger S, Nimgaonkar VL, DeshpandeSN. Feasibility, acceptability and evaluation of meditation to augment yoga practice among persons diagnosed withschizophrenia. Acta Neuropsychiatr. 2022 May 19:1-14. doi: 10.1017/neu.2022.14. Epub ahead of print. PMID:35586878.

Clinical Interests

Treatment of psychotic disorders; Treatment of cognitive disorders; Translational virology

Education Interests

Research mentorship; International research training/mentorship; Medical student & resident mentorship